Skip to main content

Simplify Regulatory Strategy & Change Management

Get up-to-date Requirements. Save time. Control risks.

home-header
01-Ayala-Pharmaceuticals 01-Ayala-Pharmaceuticals
02-Brainlab 02-Brainlab
03-B-Braun 03-B-Braun
04-Haleon 04-Haleon
05-Horizon 05-Horizon
06-Philips 06-Philips
07-Sartorious 07-Sartorious
08-Sun-Pharma 08-Sun-Pharma
09-Sunpernus-Pharma 09-Sunpernus-Pharma
10-Stryker 10-Stryker

Large, small/medium Pharma, Medical Device & Consumer Health companies

What we do

Vistaar provides Global Regulatory, Clinical and Compliance Requirements to Pharma/Biotech, Devices, Diagnostics, OTC, Consumer Health, Cosmetics and Digital Health domains. With a solid combination of smart technology and subject experts, you will get up-to-date regulatory intelligence requirements and trusted insights accurately and much faster. Vistaar has spent years compiling a comprehensive regulatory intelligence database to assist you in formulating the most effective strategies. All this is done at the best price point in the industry.

Countries-Requirements
150+

Countries Requirements

Regulations-&-Guidances
2m

Regulations & Guidance Documents

Clinical-Trials
750k

Clinical Trials

Marketed-Product-Details
371k

Marketed Product Details

Ingredients-Database
Ingredients

REGULATORY Database

How Vistaar works

Technology

Technology

Vistaar automates heavy manual processes using Automation & Artificial Intelligence (AI) to help you manage regulatory change and compliance proactively and ensure timely mitigation in your organization. End-to-end Digital design automates and simplifies data acquisition, transformation, reporting and sharing .

Global-Resources

Global Resources

Our global team of Analysts and Subject Experts, with expertise across a diverse range of industries, geographies and policy areas, collaborate with functional specialists to address questions about regulations including purpose, applicability, requirements highlights and more. All regulatory intelligence reports are vetted to ensure data and summaries are accurate and up-to-date.

Value-to-you

Value to you

  • Improve Regulatory Foresight

  • Cut down Alert Noise

  • Unifying UI for full coverage of Regulatory value chain

  • Data & Workflow Automations to reduce manual work

  • Lower Total Cost of Ownership (TCO)

Benefits

Risk Mitigation
  • Get digital centralized library that is comprehensive and covers all applicable regulations you need to be compliant with today and going forward
  • Stay on top of important regulatory developments that have direct impact on your products and organization
  • Increase accuracy and timeliness of your regulatory and compliance updates
Oversight
  • Gain operational visibility and optimize processes
  • Create a traceable matrix of laws, regulations, and guidance to do better impact assessment when changes come in
  • Reduce the noise with smart, configurable alerts that target only those regulatory changes that affect you
  • Spend up to 70% less time on process reviews by automating time-consuming tasks
Stay Ahead
  • Avoid being caught off-guard by frequent regulatory changes that could affect your products (both in R&D as well as market) and compliance programs
  • Know exactly what incoming regulatory changes apply to your organization and review internal Policies / Processes accordingly
  • Assign to teams and track the status of each important change/alert
  • Convert to documents (to share to other members) or projects (if the change is presumed big)
Business Objects
  • Link Regulatory tracking processes and Intel to Business Objectives
  • Increase team productivity by having one platform for a more collaborative approach to regulatory compliance and risk management across the company (and subsidiaries)
  • Understand and properly communicate the regulatory risks associated with your organization’s objectives and how to mitigate those to attain business goals.
  • Effectively manage all these within budgets allotted

From the Blog

|
USA Guidance on Considerations for Long-Term Clinical Neurodevelopmental Safety Studies in …
|
USA Outbreak Investigation of E. coli O157:H7: Onions (October 2024) FDA is investigatin…
|
USA FDA approves neoadjuvant/adjuvant nivolumab for resectable non-small cell lung cancer …